Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer.

@article{Benko2013ImpactOT,
  title={Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer.},
  author={Goran Benko and Borislav Spaji{\'c} and Bo{\vz}o Kru{\vs}lin and Davor Tomas},
  journal={Urologic oncology},
  year={2013},
  volume={31 4},
  pages={468-74}
}
BACKGROUND The epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein that was originally identified as a marker for carcinoma, attributable to its high expression on rapidly proliferating tumors of epithelial origin. The role of EpCAM is not limited to cell adhesion but includes diverse processes such as signaling, cell migration, proliferation, and differentiation. OBJECTIVE Several studies investigated EpCAM expression in prostate carcinoma but none of them confirmed its… CONTINUE READING
Highly Cited
This paper has 43 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 23 references

Identifi - cation of EpCAM as a molecular target of prostate cancer stroma

  • T Zellweger, C Ninck, M Bloch
  • Am J Pathol
  • 2009

Prognostic significance of paired epithelial cell adhesion molecule and E - cadherin in ovarian serous carcinoma

  • D Fong, M Steurer, P Obrist
  • Hum Pathol
  • 2009

The emerging role of EpCAM in cancer and stem cell signaling

  • RB Poczatek, RB Myers, U Manne
  • Cancer Res
  • 2009

Similar Papers

Loading similar papers…